Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

about

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

Item

http://www.wikidata.org/entity/Q48717090

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

@en

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

@nl

type

Item

label

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

@en

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

@nl

prefLabel

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

@en

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

@nl

P1476

Impaired nerve conduction velocity in MPTP-treated mouse model of Parkinson's disease.

@en

P2860

Role of axonal transport in neurodegenerative diseases

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

Detection and semi-quantitative determination of low abundance GFAP mRNA in mouse brain by capillary electrophoresis coupled with laser-induced fluorescence.

Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents.

Neurophysiological characterization of parkinsonian syndromes.

Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.

Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.

Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra.

Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation.

Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.

P304

361-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00207454.2014.933835

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Haseeb A Khan

P577

2014-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24927243

http://www.w3.org/2001/XMLSchema#string